ÃûæÂÖ±²¥

School of Life Sciences

Cell Signalling and Therapeutics (C7118)

Cell Signalling and Therapeutics

Module C7118

Module details for 2025/26.

15 credits

FHEQ Level 6

Module Outline

This module looks at the major signalling pathways in cells and how perturbations of these can result in disease processes such as cancer. Students will learn how a knowledge of these pathways has led to the design and use of specific pharmacological agents to target these pathways for therapeutic intervention. The signalling pathways covered will include RTKs, LMTK3, MAPK kinase pathways, PI-3-kinase and PKB, Jak/Stat pathways and integrins.

Module learning outcomes

Summarise the major types of signalling pathways in the cell and explain the mechanisms underlying the activation and regulation of these pathways in breast and brain cancers.

Appraise how multiple signalling pathways interact to produce a co-ordinated response to external stimuli within the body, promoting cell proliferation, survival and movement

Illustrate how dysregulation in these pathways results in a loss of growth control and the development of cancer.

Apply your knowledge of cell signalling to explain the rational design of therapeutic agents targeting these pathways in disease processes.

TypeTimingWeighting
Coursework30.00%
Coursework components. Weighted as shown below.
TestT1 Week 11 (1 hour)100.00%
Computer Based ExamSemester 1 Assessment70.00%
Timing

Submission deadlines may vary for different types of assignment/groups of students.

Weighting

Coursework components (if listed) total 100% of the overall coursework weighting value.

TermMethodDurationWeek pattern
Autumn SemesterLecture1 hour33333333333

How to read the week pattern

The numbers indicate the weeks of the term and how many events take place each week.

Dr William Jones

Assess convenor, Convenor
/profiles/526041

Please note that the University will use all reasonable endeavours to deliver courses and modules in accordance with the descriptions set out here. However, the University keeps its courses and modules under review with the aim of enhancing quality. Some changes may therefore be made to the form or content of courses or modules shown as part of the normal process of curriculum management.

The University reserves the right to make changes to the contents or methods of delivery of, or to discontinue, merge or combine modules, if such action is reasonably considered necessary by the University. If there are not sufficient student numbers to make a module viable, the University reserves the right to cancel such a module. If the University withdraws or discontinues a module, it will use its reasonable endeavours to provide a suitable alternative module.